Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
Product Unit Size | Cost | Quantity | Stock |
---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
Cas No. | 1258595-14-0 |
---|---|
Purity | ≥99% |
Formula | C29H32F2N3O7P |
Formula Wt. | 603.56 |
IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
Synonym | LHC165 |
Appearance | Pale yellow powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
mTOR inhibitor.
BRD binding agent, CDK1/2/5/9 inhibitor.
Inhibitor of EGFR, HER2, and HER3.
Flavanone found in species of Citrus. Naringen...
Prenylated chalcone flavonoid found in Psoralea...
NSAID; COX-1/2 and lactate dehydrogenase inhibi...
MAO and histone demethylase LSD1 inhibitor.
NSAID; COX-2 inhibitor.
Analog of rapamycin.
Lipopeptide; 1,3-β-Glucan synthase inhibitor.<...
Renin inhibitor.
Endogenous pterin coenzyme required for release...
B-Raf and c-Raf inhibitor.
NMDA potentiator, GABA-A antagonist.
R-type Ca2+ and voltage-gated Na+ channel block...
Acyclic nucleotide (adenosine) analog, adefovir...
Pt-based DNA cross-linker.
Alkaloid found in Corydalis and Stephania; D1/2...
Endogenous quaternary ammonium, required for fa...
PDE and adenosine deaminase inhibitor.